Font Size: a A A
Keyword [nanomedicine]
Result: 81 - 100 | Page: 5 of 6
81. RNA interference for improving the outcome of islet transplantation and polymeric micelle-based nanomedicine for cancer therapy
82. Nanomedicine for therapeutic drug therapy: Approaches to increase the efficacy of drug therapy with nanoemulsion delivery and reduce the toxicity of quantum dots
83. Nanomedicine: Targeted nanoparticles for the delivery of biosensors and therapeutic genes
84. Development of novel nanomedicine for drug delivery and photothermal cancer therap
85. Combination nanomedicine targeting cancer stem cells and bulk tumor cells for treatment of prostate cancer
86. Protective Role Of The Porous Se@SiO2 Nanoparticles In The Model Of ALI And The Mechanisms Of ALI New-onset Atrial Fibrillation And Development Of Interventional Technique
87. Tumor Microenvironment-responsive Polypeptide Nanomedicine For Prostate Cancer Chemoimmunotherapy
88. Calcium Peroxide-Loaded Efficacy-Shaping Nanomedicine And It's Anti-Prostate Cancer Application
89. Study On CXCR4 Overexpressed Cell Membrane Coated With ROS-responsive Nanomedicine For Targeted Treatment Of Ischemic Stroke
90. Strategies For Highly Efficient Cancer Therapy And Their Applications Based On Multifunctional Photodynamic Nanomaterials
91. Decitabine-Loaded Gold Nanocages For Photothermal Cancer Therapy
92. Cisplatin Nanoparticles Enhance The Sensitivity Of NSCLC To Radiotherapy And Boost Abscopal Effect
93. Efficacy And Mechanism Of Chitosan-based Nanoparticles Carrying Docetaxel And Curcumin In The Treatment Of Lung Cancer
94. In Situ Self-assembly Polypeptide Combined With Gemcitabine Prodrug For Pancreatic Cancer Treatment
95. ATM Inhibitor And TGF-? Antibody-Loaded Copper Sulfide Nanoparticles For Low-Temperature Photothermal Therapy Of Hepatocellular Carcinoma
96. Study Of The Effects And Mechanism Of Novel T7 Peptide-Modified Targeted Nanomedicine Co-loading Two Drugs For The Treatment Of Esophageal Carcinoma
97. Sulfur Dioxide Nanomedicine Enhances The Therapeutic Effects Of Doxorubicin And PD-L1 Monoclonal Antibody In Melanoma And Correlated Mechanism Analysis
98. Carrier-free Bone-targeted Nanomedicine Simultaneously Inhibits Malignant Bone Tumor And Tumor-associated Osteolysis
99. Co-delivery Of TGF-? Inhibitor And Doxorubicin By Nanocarrier For Improving Cancer Chemotherapy And Immunotherapy
100. Patient-derived Cancer Organoids For The Development Of Combinatorial Nanomedicines
  <<First  <Prev  Next>  Last>>  Jump to